Market Place
Sourcing Support
All News #Library
Generics
Gilenya (Fingolimod): Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
18 Jul 2018 //
PATENT LITIGATION
Senispar® (cinacalcet hydrochloride): Amgen Inc. v. Accord Healthcare, Inc. and Intas Pharmaceuticals Ltd.
29 Jun 2018 //
PATENT LITIGATION
Intas puts the fizz back into ex-Sanofi plant with generic effervescents
31 Jan 2018 //
IN PHARMATECHNOLOGIST
Intas low-balls Mallinckrodt unit bid to $1bn on legal fears
11 Jan 2018 //
ECONOMIC TIMES
Intas closing in on Mallinckrodt’s US generics business
01 Nov 2017 //
ECONOMIC TIMES
Intas Pharmaceuticals to go for $4-billion deals in a month
14 Sep 2017 //
BUSINESS-STANDARD
Aurobindo Pharma, Intas in race to buy Mallinckrodt`s US generic business
09 Aug 2017 //
MONEYCONTROL
Pharma companies increase investments for global biosimilar push
24 Oct 2016 //
BUSINESS STANDARD
Intas Pharma to acquire generics business of Actavis in UK & Ireland
06 Oct 2016 //
PHARMABIZ
Intas Pharmaceuticals Launches INTACEPT, The First Etanercept Biosimilar
28 Mar 2015 //
THE FINANCIAL EXPRESS
Intas Enters The European Market
25 Mar 2015 //
BIOSPECTRUM
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.